Public Employees Retirement Association of Colorado’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,409
Closed -$23K 1959
2023
Q1
$23K Hold
15,409
﹤0.01% 1941
2022
Q4
$39K Hold
15,409
﹤0.01% 1917
2022
Q3
$65K Hold
15,409
﹤0.01% 1865
2022
Q2
$43K Hold
15,409
﹤0.01% 1922
2022
Q1
$88K Hold
15,409
﹤0.01% 1858
2021
Q4
$141K Hold
15,409
﹤0.01% 1818
2021
Q3
$165K Hold
15,409
﹤0.01% 1772
2021
Q2
$239K Hold
15,409
﹤0.01% 1672
2021
Q1
$250K Hold
15,409
﹤0.01% 1623
2020
Q4
$326K Hold
15,409
﹤0.01% 1407
2020
Q3
$228K Hold
15,409
﹤0.01% 1468
2020
Q2
$227K Hold
15,409
﹤0.01% 1453
2020
Q1
$181K Buy
15,409
+8,335
+118% +$157K ﹤0.01% 1412
2019
Q4
$166K Hold
7,074
﹤0.01% 1600
2019
Q3
$131K Hold
7,074
﹤0.01% 1662
2019
Q2
$132K Hold
7,074
﹤0.01% 1714
2019
Q1
$173K Hold
7,074
﹤0.01% 1590
2018
Q4
$183K Hold
7,074
﹤0.01% 1538
2018
Q3
$224K Buy
+7,074
New +$263K ﹤0.01% 1590

Other funds holding HRTX

Public Employees Retirement Association of Colorado's HRTX Position: Q2 2023 in Review

Public Employees Retirement Association of Colorado sold out of Heron Therapeutics (HRTX) in Q2 2023, closing a stake of 15,409 shares — an estimated $23K sold.

Public Employees Retirement Association of Colorado first reported a position in HRTX in Q3 2018 and held it in 19 quarters. The position peaked at $326K in Q4 2020. 149 funds tracked by Wall St. Rank hold HRTX as of Q2 2023.

  • Public Employees Retirement Association of Colorado reported no remaining Heron Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Public Employees Retirement Association of Colorado sold 15,409 Heron Therapeutics shares in Q2 2023, an estimated $23K.
  • Public Employees Retirement Association of Colorado first reported a position in Heron Therapeutics in Q3 2018 and held it in 19 quarters.
  • Public Employees Retirement Association of Colorado's Heron Therapeutics position peaked at $326K in Q4 2020.
  • 149 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2023.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2023, filed 9 Aug 2023.